{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "NF1",
                "DNA Alteration": "c.6926del",
                "GeneMutation": "p.N1465S Spliceregionvariant-LOF",
                "VariantAlleleFraction": "12.41%"
            },
            {
                "Gene": "BRCA1",
                "DNA Alteration": "c.68_69delAG",
                "GeneMutation": "p.Q1756Pfs Frameshift-GOF",
                "VariantAlleleFraction": "9.58%"
            },
            {
                "Gene": "NCSTN",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.A572G Spliceregionvariant-GOF",
                "VariantAlleleFraction": "10.81%"
            },
            {
                "Gene": "FGFR3",
                "DNA Alteration": "c.746C>G",
                "GeneMutation": "p.G380R Nonsense-GOF",
                "VariantAlleleFraction": "7.54%"
            },
            {
                "Gene": "SMO",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.A374E Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "6.67%"
            },
            {
                "Gene": "PTPN11",
                "DNA Alteration": "c.1508G>C",
                "GeneMutation": "p.G503A Stopgain-LOF",
                "VariantAlleleFraction": "7.27%"
            },
            {
                "Gene": "CSF3R",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.G751A Frameshift-LOF",
                "VariantAlleleFraction": "2.92%"
            }
        ],
        "Germline": [
            {
                "Gene": "PAX5",
                "DNA Alteration": "c.547G>A",
                "GeneMutation": "p.A322T Spliceregionvariant-LOF",
                "Condition": "important"
            }
        ]
    }
}